Literature DB >> 32649863

Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.

Timothy Travers1, Cesar A López2, Constance Agamasu3, Jeevapani J Hettige2, Simon Messing3, Angel E García4, Andrew G Stephen3, S Gnanakaran5.   

Abstract

CRAF activation requires binding to membrane-anchored and active GTP-bound RAS. Whereas its RAS-binding domain (RBD) contains the main binding interface to the RAS G domain, its cysteine-rich domain (CRD) is responsible for association to anionic lipid-rich membranes. Both RAF domains are connected by a short linker, and it remains unclear if the two domains act independently or if one domain can impact the function of the other. Here, we used a combination of coarse-grained and all-atom molecular dynamics simulations of a CRAF RBD-CRD construct to investigate the dynamics of the RBD when it is tethered to CRD that is anchored to a POPC:POPS model membrane. First, we show that the RBD positioning is very dynamic with a preferential localization near the membrane surface. Next, we show that membrane-localized RBD has its RAS-binding interface mostly inaccessible because of its proximity to the membrane. Several positively charged residues in this interface were identified from simulations as important for driving RBD association to the membrane. Surface plasmon resonance (SPR) measurements confirmed that mutations of these RBD residues reduced the liposome partitioning of RBD-CRD. Last, simulations indicated that the presence of RBD near the membrane led to a local enrichment of anionic lipids that could potentially enhance the membrane affinity of the entire RBD-CRD construct. This was supported by SPR measurements that showed stronger liposome partitioning of RBD-CRD relative to CRD alone. These findings thus suggest that the RBD and CRD have synergistic effects on their membrane dynamics, with CRD bringing RBD closer to the membrane that impacts its accessibility to RAS and with RBD causing local anionic lipid enrichment that enhances the overall affinity between the membrane and RBD-CRD. These mechanisms have potential implications on the order of events of the interactions between RAS and CRAF at the membrane.
Copyright © 2020 Biophysical Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32649863      PMCID: PMC7399501          DOI: 10.1016/j.bpj.2020.06.021

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  74 in total

1.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

Review 2.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

3.  Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis.

Authors:  Linda J Pike; Xianlin Han; Koong-Nah Chung; Richard W Gross
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

4.  Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.

Authors:  Krishnaraj Rajalingam; Christian Wunder; Volker Brinkmann; Yuri Churin; Mirko Hekman; Claudia Sievers; Ulf R Rapp; Thomas Rudel
Journal:  Nat Cell Biol       Date:  2005-07-24       Impact factor: 28.824

5.  Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.

Authors:  Srisathiyanarayanan Dharmaiah; Lakshman Bindu; Timothy H Tran; William K Gillette; Peter H Frank; Rodolfo Ghirlando; Dwight V Nissley; Dominic Esposito; Frank McCormick; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

6.  Computational Modeling Reveals that Signaling Lipids Modulate the Orientation of K-Ras4A at the Membrane Reflecting Protein Topology.

Authors:  Zhen-Lu Li; Matthias Buck
Journal:  Structure       Date:  2017-03-09       Impact factor: 5.006

7.  The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.

Authors:  Gernot Polier; Jennifer Neumann; Frédéric Thuaud; Nigel Ribeiro; Christoph Gelhaus; Hendrik Schmidt; Marco Giaisi; Rebecca Köhler; Wolfgang W Müller; Peter Proksch; Matthias Leippe; Ottmar Janssen; Laurent Désaubry; Peter H Krammer; Min Li-Weber
Journal:  Chem Biol       Date:  2012-09-21

8.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

9.  Oncogenic K-Ras Binds to an Anionic Membrane in Two Distinct Orientations: A Molecular Dynamics Analysis.

Authors:  Priyanka Prakash; Yong Zhou; Hong Liang; John F Hancock; Alemayehu A Gorfe
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

10.  Anionic lipids and the maintenance of membrane electrostatics in eukaryotes.

Authors:  Matthieu Pierre Platre; Yvon Jaillais
Journal:  Plant Signal Behav       Date:  2017-02
View more
  3 in total

Review 1.  Ras Multimers on the Membrane: Many Ways for a Heart-to-Heart Conversation.

Authors:  E Sila Ozdemir; Anna M Koester; Xiaolin Nan
Journal:  Genes (Basel)       Date:  2022-01-25       Impact factor: 4.096

2.  Unveiling the Dynamics of KRAS4b on Lipid Model Membranes.

Authors:  Cesar A López; Animesh Agarwal; Que N Van; Andrew G Stephen; S Gnanakaran
Journal:  J Membr Biol       Date:  2021-04-07       Impact factor: 1.843

3.  Nanoscopic Spatial Association between Ras and Phosphatidylserine on the Cell Membrane Studied with Multicolor Super Resolution Microscopy.

Authors:  Anna M Koester; Kai Tao; Malwina Szczepaniak; Matthew J Rames; Xiaolin Nan
Journal:  Biomolecules       Date:  2022-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.